Get started
Author

Sudpreeda Chainitikun

Observed name: S. Chainitikun
Institution: MedPark Hospital
ORCID: 0000-0002-7738-9945
Observed ORCID: 0000-0002-7738-9945
OpenAlex ID: A5088164483
Update on systemic treatment for newly diagnosed inflammatory breast cancer
2020 · Sudpreeda Chainitikun, Sadia Saleem, et al. · Journal of Advanced Research · 57
PDF
Targeting Signaling Pathways in Inflammatory Breast Cancer
2020 · Xiaoping Wang, Takashi Semba, et al. · Cancers · 42
PDF
The Prognostic Impact of Body Composition for Locally Advanced Breast Cancer Patients Who Received Neoadjuvant Chemotherapy
2021 · Toshiaki Iwase, Aaroh Parikh, et al. · Cancers · 19
PDF
Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review
2021 · Sudpreeda Chainitikun, Jose Rodrigo Espinosa Fernandez, et al. · PLoS ONE · 9
The efficacy of first-line chemotherapy in endocrine-resistant hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) metastatic breast cancer
2020 · Sudpreeda Chainitikun, James P. Long, et al. · Breast Cancer Research and Treatment · 9
Bone Metastases: Mechanisms of the Metastatic Process, Imaging and Therapy
2020 · Colleen M. Costelloe, Patrick P. Lin, et al. · Seminars in Ultrasound CT and MRI · 7
Circulating cancer-associated macrophage-like cells and macrophage-related cytokines in obese patients with advanced breast cancer who undergo neoadjuvant chemotherapy
2024 · Toshiaki Iwase, Aaroh Parikh, et al. · Journal of Cancer · 3
PDF
What is the best systemic treatment for newly diagnosed inflammatory breast cancer?—a narrative review
2021 · Sudpreeda Chainitikun, Siyamol Mingmalairak, et al. · Chinese Clinical Oncology · 2
PDF
Validation of Prognostic Stage and Anatomic Stage in the American Joint Committee on Cancer 8th Edition for Inflammatory Breast Cancer
2020 · Kumiko Kida, Kenneth R. Hess, et al. · Cancers · 2
PDF
Bone Metastases
2022 · Colleen M. Costelloe, Patrick P. Lin, et al. · Elsevier eBooks · 1
The efficacy of first-line chemotherapy in endocrine-resistant hormone receptor-positive (HR+), human epidermal growth factor receptor 2- negative (HER2-) metastatic breast cancer (MBC).
2020 · Sudpreeda Chainitikun, James Long, et al. · Journal of Clinical Oncology · 1
Prevalence of immune-related adverse events (irAEs) and association with symptom distress score by Edmonton Symptom Assessment System (ESAS) in solid cancer patients receiving immune checkpoint inhibitor (ICI) therapy.
2025 · Sudpreeda Chainitikun, Siyamol Mingmalairak, et al. · Journal of Clinical Oncology
Unusual Pattern of Spread of High-Grade Serous Fallopian Tubal Carcinoma in a Woman with BRCA1 Gene Mutation
2024 · Siriwan Tangjitgamol, Sudpreeda Chainitikun, et al. · Vajira Medical Journal: Journal of Urban Medicine
Contributors
2022 · Eddie K. Abdalla, Jitesh Ahuja, et al. · Elsevier eBooks
Abstract PS2-23: Prospective study of circulating cancer-associated macrophage-like cells (CAMLs) in obese patients with advanced breast cancer
2021 · Toshiaki Iwase, Aaroh Parikh, et al. · Cancer Research
Abstract P5-06-10: Validation of prognostic stage and anatomic stage in the American joint committee on cancer 8th edition for inflammatory breast cancer
2020 · Kumiko Kida, Kenneth R Hess, et al. · Cancer Research
Incremental cost-effectiveness analysis of hepatic metastasectomy in patients with advanced colon cancer and liver metastasis
2016 · S. Chainitikun · Annals of Oncology
PDF
Works count: 17
Citation count: 152
H-index: 6
I10-index: 3
Year
Topic
Type